Transcatheter Mitral Valve Market Report 2026

Transcatheter Mitral Valve Market Overview

• Transcatheter Mitral Valve market size has reached to $1.61 billion in 2025 • Expected to grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Increasing Prevalence Of Heart Diseases Fueling The Growth Of The Market Due To Rising Aging Population And Associated Cardiovascular Risks • Market Trend: Advancements In Transcatheter Mitral Valve Replacement System To Improve Patient Outcomes And Minimally Invasive Treatment Options • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Transcatheter Mitral Valve Market?

A transcatheter mitral valve is a minimally invasive medical device used to repair or replace a damaged mitral valve without the need for open-heart surgery. It is placed in the heart using a thin tube inserted through a vein or artery, helping improve blood flow and reduce symptoms of mitral valve disease. This procedure is particularly advantageous for patients at high risk for conventional surgery. The main product types of transcatheter mitral valves are transcatheter mitral valve replacement and transcatheter mitral valve repair. Transcatheter mitral valve replacement is a minimally invasive procedure where a new artificial or biological mitral valve is inserted into the heart using a catheter, typically through a blood vessel. It is used for various indications, such as mitral stenosis and mitral regurgitation, and is used by several end users, including hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.

What Is The Transcatheter Mitral Valve Market Growth Forecast?

The transcatheter mitral valve market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to technological advancement in transcatheter valve designs, rising geriatric population with mitral valve disorders, expansion of cardiac catheterization laboratories, increasing healthcare expenditure, adoption of minimally invasive cardiac intervention programs. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, increasing use of self-expanding and balloon-expandable valves, expansion of edge-to-edge and chordal repair devices, growing prevalence of mitral valve diseases among elderly patients, integration of imaging and navigation systems for procedure accuracy.

Global Transcatheter Mitral Valve Market Segmentation

1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair 2) By Indication: Mitral Stenosis, Mitral Regurgitation 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories Subsegments: 1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves 2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices

What Is The Driver Of The Transcatheter Mitral Valve Market?

The increasing prevalence of heart diseases is expected to propel the growth of the transcatheter mitral valve market going forward. Heart diseases are disorders that disrupt the heart’s structure or function, reducing its efficiency in pumping blood. The growing prevalence of heart diseases is driven by aging populations, as age-related deterioration of the heart and blood vessels increases vulnerability to conditions such as mitral valve regurgitation, heart failure, and arrhythmias. A transcatheter mitral valve helps treat heart disease by fixing or replacing a damaged mitral valve to restore healthy blood flow between the heart’s chambers, improving heart function and easing symptoms. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, between 2025 and 2050, cardiovascular disease is projected to rise significantly, with prevalence increasing by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, leading to an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. Therefore, the increasing prevalence of heart diseases is driving the growth of the transcatheter mitral valve industry.

Key Players In The Global Transcatheter Mitral Valve Market

Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.

Global Transcatheter Mitral Valve Market Trends and Insights

Major companies operating in the transcatheter mitral valve market are focusing on developing advanced products such as transcatheter mitral valve replacement systems to expand treatment options for high-risk or inoperable patients. Transcatheter mitral valve replacement (TMVR) systems refer to a minimally invasive medical device that replaces a damaged or diseased mitral valve in the heart with an artificial valve using a catheter-based approach, avoiding the need for open-heart surgery. For instance, in May 2025, Abbott Laboratories, a US-based medical device company, launched Tendyne, which received approval from the Food and Drug Administration (FDA). It is a self-expanding, nitinol-framed valve available in multiple sizes to accommodate varied anatomies and can be fully repositioned or retrieved during implantation. Delivered through a small incision in the chest, the system enables a minimally invasive procedure typically completed in about 1.5 hours. Designed for faster recovery, the system allows most patients to be discharged within three days, offering a transformative solution for high-risk mitral valve patients who lack viable surgical alternatives.

What Are Latest Mergers And Acquisitions In The Transcatheter Mitral Valve Market?

In April 2024, TechWald Holding S.p.A., an Italy-based company that invests in medical technologies, acquired Valcare Medical Inc. for an undisclosed amount. With this acquisition, TechWald Holding aims to expand its presence in the structural heart device market, focusing on transcatheter mitral valve repair and replacement. The deal boosts its cardiovascular portfolio, speeds up Valcare’s device development and commercialization, and strengthens its position in minimally invasive heart valve therapies. Valcare Medical Inc. is an Israel-based company that offers minimally invasive transcatheter treatments for mitral regurgitation.

Regional Outlook

North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Transcatheter Mitral Valve Market?

The transcatheter mitral valve market consists of sales of transcatheter annuloplasty devices, guiding catheters, chordal repair devices, and adjunctive imaging and navigation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.